Media



Ulf Wiinberg appointed new CEO of Lundbeck

Launch webcast of press conference

Scientific publications

Read abstracts of scientific articles written by Lundbeck employees about Lundbeck's products and research. 

Read more about Scientific publications

Image Library

Download ready-to-use press images for your article or broadcast.

Read more about Image Library
15-May-2008
Share Buyback in H. Lundbeck A/S
Acting on its authorization to acquire up to 10% of its shares, Lundbeck's Supervisory Board has resolved to initiate a share buyback program. Under the program Lundbeck will buy own shares for an amount of up to DKK 6 billion, cf. stock exchange announcement number 166 dated 17 August 2005. The buyback program is expected to be completed by the end of 2008.
13-May-2008
Circadin® launch rollout starts with the launch of the product in the important German market
Lundbeck today announced the launch of Circadin® for insomnia in Germany. Circadin® was approved by the European Commission on 29 June 2007, and Lundbeck expects to launch the product in another 14 markets during 2008.
View all releases

Media Relations Contact

Jens Harder Højbjerg
Jens Harder Højbjerg
Media Relations Manager
Corporate Communication
Tel:   +45 3643 2833
Mob: +45 3083 2833
Fax:  +45 3643 8262
jehh@lundbeck.com
Mads Vindahl Kronborg
Mads Vindahl Kronborg
Communication Specialist
Corporate Communication
Tel:  +45 3643 2851
Mob: +45 3083 2851
Fax:  +45 3643 8262
mavk@lundbeck.com
Anders Schroll
Anders Schroll
Head of
Corporate Communication
Tel:  +45 3643 2081
Mob: +45 3083 2081
Fax:  +45 3643 8262
asch@lundbeck.com
 
H. Lundbeck A/S
Ottiliavej 9
DK-2500 Copenhagen Valby
Tel +45 36 30 13 11
Fax +45 36 30 19 40
information@lundbeck.com
The specialist in psychiatry and pioneer in neurology
Disclaimer & Privacy statement